BETAGENE, INC.

Follow

Organization

DALLAS, TX, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Recombinant expression of proteins from secretory cell lines
- Patent number 6,194,176
- Issue date Feb 27, 2001
- Board of Regents, The University of Texas System
- Christopher B. Newgard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions relating to no-mediated cytotoxicity
- Patent number 6,171,856
- Issue date Jan 9, 2001
- Board of Regents, The University of Texas System
- Anice Thigpen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant expression of proteins from secretory cell lines
- Patent number 6,110,707
- Issue date Aug 29, 2000
- Board of Regents, The University of Texas System
- Christopher B. Newgard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant expression of proteins from secretory cell lines
- Patent number 6,087,129
- Issue date Jul 11, 2000
- Betagene, Inc.
- Christopher B. Newgard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting hexokinase
- Patent number 5,891,717
- Issue date Apr 6, 1999
- Betagene, Inc.
- Christopher B. Newgard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hexokinase inhibitors
- Patent number 5,854,067
- Issue date Dec 29, 1998
- Board of Regents, The University of Texas System
- Christopher B. Newgard
- C07 - ORGANIC CHEMISTRY

NIH Research Projectlast 12 months

processing...

Count: 2

Research Projects

Information Research Project
HUMAN NEUROENDOCRINE CELL LINES FOR DIABETES THERAPY
- Application id 6210739
- Award notice date Sep 1, 2000
Information Research Project
ENGINEERED BETA CELL LINES AS DISCOVERY TOOLS
- Application id 2793000
- Award notice date Mar 26, 1999